; and (2) by adding at the end the following: (ii) Additional information Beginning with fiscal year 2018, the annual report under this subparagraph shall include the progress of the Center for Devices and Radiological Health in achieving the goals, and future plans for meeting the goals, including, for each review division— (I) the number of premarket applications filed under section 515 per fiscal year for each review division, and the number of approvable letters, major deficiency letters, not approvable letters, and denials for such applications; (II) the number of reports filed under section 510(k) per fiscal year for each review division and the number of devices cleared or not substantially equivalent for such reports; and (III) the number of expedited access pathway designations for a fiscal year for each review division and the number of cleared or approved devices or denials for such applications. (iii) Real time reporting (I) In general Beginning with fiscal year 2018, the Secretary shall, every 30 calendar days, post the data described in subclause (II) on the Internet website of the Food and Drug Administration and remove from such website duplicative data from the annual report under this subparagraph. (II) Data The following data is required to be posted in accordance with subclause (I): (aa) The number and titles of draft and final guidance issued by the Center for Devices and Radiological Health and the justification for the issuance and finalization of such guidance. (bb) The number and titles of public meetings held by the Center for Devices and Radiological Health each fiscal year. . (c) GDUFA Section 744C(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–43(a) ) is amended— (1) by striking Beginning with and inserting the following: (1) General requirements Beginning with